Related Experiment Video
Updated: Feb 28, 2026

A Protein Preparation Method for the High-throughput Identification of Proteins Interacting with a Nuclear Cofactor Using LC-MS/MS Analysis
Published on: January 24, 2017
Competitive LC-MS/MS assay to investigate protein metalation dynamics
Kira Küssner1, Michael Wolf2,3, Andrea Cucchiaro1
1Institute for Pharmacy, Pharmaceutical Chemistry, Department of Chemistry and Pharmacy, Center for Molecular Bioscience (CMBI), University of Innsbruck Innrain 80/82 A-6020 Innsbruck Austria monika.cziferszky@uibk.ac.at.
Abstract:
Knowledge gaps in the biospeciation of potential metallodrugs may lead to the generalized assumption of their promiscuous reactivity and inherent toxicity, neglecting their pharmaceutical potential. Herein, we developed a rapid and competitive LC-MS/MS assay to determine metalation dynamics of protein mixtures by metallodrugs. Specifically, the time-dependent reactivity of different metallodrugs, based on platinum(ii) (cisplatin, [Pt(ala)(ASA-But)Cl]), ruthenium(ii) ([Ru(HQ)(Cym)Cl], [Ru(NHC)(Cym)Cl2]), and iridium(iii) ([Ir(HQ)(Cp*)Cl], [Ir(NHC)(Cp*)Cl2]), towards an equimolar protein mixture was investigated. The assay revealed metal-dependent selectivity of adduct formation and subsequent deactivation by cellular detoxifying nucleophiles, e.g. glutathione (GSH). Online top-down fragmentation further enabled the localization of binding sites of metallodrugs on proteins in the same run, which could be directly related to complex speciation behaviour. The reactivity of Zeise's salt derivative [Pt(ala)(ASA-But)Cl] (ala = l-alanine; ASA-But = but-3-en-1-yl 2-acetoxybenzoate) with sulfur donor atoms was found to exceed all investigated compounds, including cisplatin. Ruthenium compounds preferred N-donor coordination, which resulted in a strong affinity towards histidine residues. Protein adducts of the somewhat redox-active iridium compounds were quickly transformed into stable adducts with detoxifying nucleophiles, especially with GSH. This model system provides further evidence that metallodrug reactivity is more selective in competitive settings, as would be anticipated from exposure to single biomolecules. This implies that the intracellular selectivity of metallodrugs can be chemically tuned and that this aspect may be accounted for in future metallodrug design. Such design strategies will be supported by expanding the present competitive assay to more complex systems that better mimic physiological intra- and extracellular tumour microenvironments.
More Related Videos
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
09:51Standards for Quantitative Metalloproteomic Analysis Using Size Exclusion ICP-MS
Published on: April 13, 2016